TP53 and head and neck squamous cell carcinoma: Genome sequencing data of HNSCC cases have revealed that 50–63% of TP53 mutations are missense with the remainder (16% nonsense, 16% insertion/deletion, and 8% splice site mutations) predicted to be inactivating mutations [15,16].